Overview
Wholesale Trade

VITAL KSK HOLDINGS,INC.

Vital KSK Holdings is a holding company operating primarily in pharmaceutical wholesale distribution through its core subsidiaries Vital Net and KSK, serving hospitals, clinics, and pharmacies across Japan. The group also operates pharmacy (dispensing) businesses, veterinary pharmaceutical wholesale, and ancillary services including healthcare consulting, logistics, and nursing care. Its diversified structure across the pharmaceutical supply chain provides resilience and broad geographic coverage within Japan.

Market Cap
¥75.2B
US$479M
EV
¥8.95B
US$57.0M
Stock¥1,565▼-0.19%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
1.1
x
LTM EV/EBIT
1.9
x
LTM PER
10.7
x
LTM PBR
0.7
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▲+0.5%pt
1001
Oct 24, 25 – Oct 23, 26StockTOPIX
1Feb 27, 26Q2 FY2026 earnings announcement
MC → EV Bridge
75.2BUS$479MMarket Cap7.03BUS$44.9M+ Debt22.8BUS$145M− Cash52.0BUS$332M− Inv. Sec.1.50BUS$9.57M+ NCI8.95BUS$57.0MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
577US$3.68B'22/3580US$3.70B'23/3587US$3.75B'24/3600US$3.83B'25/3610US$3.89B'26/3
EBITDA 5Y (¥B)
5.73US$36.5M'22/35.48US$34.9M'23/38.81US$56.2M'24/39.36US$59.7M'25/37.88US$50.2M'26/3
Net Income 5Y (¥B)
4.77US$30.4M'22/34.83US$30.8M'23/35.84US$37.3M'24/37.31US$46.6M'25/37.36US$47.0M'26/3
Capital Structure
94%
EquityD/E 0.06xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
74.5US$475M11.8US$75.6M'22/363.7US$406M10.2US$65.4M'23/381.7US$521M9.11US$58.1M'24/368.2US$435M8.54US$54.5M'25/376.0US$485M7.29US$46.5M'26/3
Shareholders
Top 10 hold 37.5%
1
MH LLC
10.09%
2
The Master Trust Bank of Japan, Ltd. (Trust Account)
7.92%
3
STATE STREET BANK AND TRUST COMPANY 505103 (Standing Proxy: Mizuho Bank, Ltd.)
2.91%
4
Ken SUZUKI
2.85%
5
VITAL KSK HOLDINGS,INC. Employee Stock Ownership Association
2.63%
6
Custody Bank of Japan, Ltd. (Trust Account)
2.52%
7
Kueko Co., Ltd.
2.44%
8
Koichiro SUZUKI
2.12%
9
Mizuho Trust & Banking Co., Ltd. Retirement Benefit Trust
2.09%
10
Employee Stock Ownership Association
1.97%
Management
12 officers
Taisuke MURAI
Representative Director, President
Apr 1987 Joined Sanes Co., Ltd. (now Vital-Net Co., Ltd.) Oct 1989 General Manager, Corporate Planning Office, Sanes Jun 1990 Director, Sanes Jun 1994 Managing Director, Sanes Apr 1996 General Manager, Sales Headquarters, Sanes Apr 1997 Senior Managing Director, Sanes Jun 2006 Director and Vice President, Vital-Net Jun 2006 Assistant to the President, in charge of External Relations and IR, Vital-Net Apr 2009 Director of the Company, in charge of Corporate Planning Jun 2014 Representative Director, Executive Vice President, Executive Officer, Assistant to the President, in charge of External Relations, Vital-Net Jun 2014 Director, Fineness Co., Ltd. (current) Jun 2015 Representative Director, Vital-Net (current) Jun 2015 Representative Director, President of the Company Jun 2017 Representative Director, President, CEO and CIO of the Company Jun 2018 Director, KSK Co., Ltd. (current) Jun 2019 Representative Director, President, CEO, CIO and in charge of Corporate Planning of the Company (current) Sep 2025 Director, Medrip Pharma Co., Ltd. (current) Significant Concurrent Positions: Representative Director, Vital-Net; Director, KSK Co., Ltd.; Director, Fineness Co., Ltd.; Director, Medrip Pharma Co., Ltd.
1954-04-01
Takeshi ICHIJO
Representative Director, Executive Vice President
Apr 1985 Joined Sanes Co., Ltd. (now Vital-Net Co., Ltd.) Apr 1997 General Manager, Fukushima Branch, Sanes Oct 2002 General Manager, Yamagata Sales Department, Vital-Net Jul 2006 Executive Officer, General Manager, Miyagi Sales Department, Vital-Net Jul 2009 Executive Officer, General Manager, Sales Headquarters, Vital-Net Jun 2010 Director, Vital-Net Jun 2012 Director of the Company Jul 2012 Director of the Company, in charge of Sales (Vital-Net) Jul 2012 Managing Executive Officer, Director, Vital-Net Jul 2013 Director of the Company, in charge of Sales and Purchasing Jun 2015 Representative Director, President, Vital-Net (current) Jun 2015 Director of the Company, in charge of External Relations Jun 2017 Director of the Company, in charge of Sales Jun 2018 Director of the Company, in charge of IR Jun 2019 Director of the Company, in charge of Sales and Purchasing Jun 2020 Director and Vice President of the Company, in charge of Sales, Purchasing and External Relations Jun 2021 Representative Director, Executive Vice President of the Company, in charge of Sales, Purchasing and External Relations Jun 2023 Representative Director, Executive Vice President of the Company, in charge of External Relations and Pharmacy Business (current) Sep 2025 Director, Medrip Pharma Co., Ltd. (current) Significant Concurrent Positions: Representative Director, President, Vital-Net; Director, Medrip Pharma Co., Ltd.
1959-10-16
Yoriyuki IGUCHI
Representative Director, Executive Vice President
Apr 1990 Joined Daigo Co., Ltd. (now KSK Co., Ltd.) Apr 2010 General Manager, Nagahama Branch, KSK Jul 2017 Executive Officer, General Manager, Keishi Sales Department, KSK May 2019 Executive Officer, General Manager, Human Resources Department, KSK Jun 2019 Director, General Manager, General Affairs Department and General Manager, Human Resources Department, KSK Jun 2020 Director, General Manager, Administration Division, General Manager, Human Resources Department, in charge of Corporate Planning and Affiliated Companies, KSK Jun 2020 Executive Officer, General Manager, Legal and Compliance Department, the Company Jun 2021 Director, General Manager, Administration Division, General Manager, Human Resources Department, in charge of Audit and Legal and Compliance, KSK Jun 2021 Director of the Company, in charge of CSR, General Affairs, Human Resources, Legal and Compliance, and Audit Jun 2023 Director, General Manager, Administration Division, General Manager, Human Resources Department, KSK Apr 2025 Director, General Manager, Administration Division, KSK Jun 2025 Representative Director, President, KSK (current) Jun 2025 Director, Vital-Net (current) Jun 2025 Representative Director, Executive Vice President of the Company, in charge of CSR, Sustainability Promotion, General Affairs and Human Resources, Legal and Compliance, and Audit (current) Sep 2025 Director, Medrip Pharma Co., Ltd. (current) Significant Concurrent Positions: Representative Director, President, KSK Co., Ltd.; Director, Vital-Net; Director, Medrip Pharma Co., Ltd.
1968-03-16
Mitsunao SUZUKI
Director
Jul 2008 Joined Vital-Net Jul 2010 General Manager, Sales Development Office, Vital-Net Jul 2013 General Manager, Sendai Branch, Vital-Net Jul 2014 General Manager, Miyagi Sales Department, Vital-Net Jul 2015 Executive Officer, General Manager, Sales Headquarters and General Manager, Sales Strategy Department, Vital-Net Jun 2016 Director and Executive Officer, General Manager, Sales Headquarters and General Manager, Sales Strategy Department, Vital-Net Jul 2020 Director and Managing Executive Officer, General Manager, Sales Headquarters, Vital-Net Jul 2022 Executive Officer, Deputy General Manager in charge of Sales and Purchasing and General Manager in charge of MAPs, the Company Jun 2023 Director of the Company, in charge of Sales and Purchasing and MAPs Jun 2023 Outside Director, Hokuyaku Co., Ltd. (current) Jun 2023 Outside Director, Astem Co., Ltd. (current) Jun 2023 Director and Vice President, Executive Officer, General Manager, Sales Headquarters, Vital-Net Jun 2024 Representative Director, Vice President, in charge of Management and Sales, Vital-Net (current) Jun 2025 Director of the Company, in charge of Corporate Communications and Business Development (current) Sep 2025 Director, Medrip Pharma Co., Ltd. (current) Significant Concurrent Positions: Director and Vice President, Vital-Net; Outside Director, Hokuyaku Co., Ltd.; Outside Director, Astem Co., Ltd.; Director, Medrip Pharma Co., Ltd.
1977-10-17
Koichiro SUZUKI
Director
Aug 2000 Joined Nichie Co., Ltd. (now Vital-Net Co., Ltd.) Jul 2008 General Manager, Niigata No. 2 Branch, Vital-Net Jul 2011 General Manager, Niigata Sales Department, Vital-Net Jul 2014 Executive Officer, Vital-Net Jun 2017 Director and Executive Officer, Deputy General Manager, Sales Headquarters, General Manager, Sales Strategy Department, in charge of Niigata, Vital-Net Jul 2018 Director and Executive Officer, Deputy General Manager, Sales Headquarters, in charge of Sales Strategy and Niigata, Vital-Net Jul 2019 Director and Executive Officer, Deputy General Manager, Sales Headquarters, General Manager, Pharmaceutical Department, in charge of Niigata, Vital-Net Jul 2020 Director and Executive Officer, Deputy General Manager, Sales Headquarters, General Manager, Pharmaceutical Department, in charge of Kanetsu, Vital-Net Jul 2021 Director and Executive Officer, Deputy General Manager, Sales Headquarters, General Manager, Pharmaceutical Department, Vital-Net Jul 2022 Director and Executive Officer, Deputy General Manager, Sales Headquarters, General Manager, Distribution Division, Vital-Net Jun 2023 Director of the Company, in charge of Business Development Jun 2023 Director and Managing Executive Officer, Deputy General Manager, Sales Headquarters, General Manager, Distribution Division, Vital-Net Jun 2024 Director and Managing Executive Officer, General Manager, Sales Headquarters, Vital-Net (current) Jun 2025 Director of the Company, in charge of Sales and Purchasing (current) Significant Concurrent Positions: Director, Vital-Net
1974-11-21
Isao KITA
Director
Apr 1989 Joined The Taiyo Kobe Bank, Ltd. (now Sumitomo Mitsui Banking Corporation) Apr 2017 Branch Manager, Sakai Area Branch, Sumitomo Mitsui Banking Corporation May 2019 Managing Officer, Accounting and Finance Department, the Company Jul 2019 Executive Officer in charge of Finance, KSK Jun 2020 Director in charge of Finance and Credit Management, KSK Jun 2021 Director in charge of Credit Management and Business Reform Promotion, and Finance, Corporate Planning, Information Systems and Affiliated Companies, KSK Jul 2021 Managing Officer, Accounting and Finance Department, the Company Jul 2022 General Manager, Accounting and Finance Department, the Company Jun 2023 Director of the Company, in charge of Accounting and Finance (current) Jun 2025 Representative Director, KSK, in charge of Credit Management, Business Reform Promotion, Finance, Corporate Planning and Affiliated Companies (current) Sep 2025 Statutory Auditor, Medrip Pharma Co., Ltd. (current) Significant Concurrent Positions: Representative Director, KSK Co., Ltd.; Statutory Auditor, Medrip Pharma Co., Ltd.
1966-11-15
Kiyoko ONOGI
Director
Oct 1979 Joined the Ministry of Posts and Telecommunications (recruited by Morioka Regional Postal Savings Bureau) Apr 2005 Deputy Postmaster, Kogota Post Office, Miyagi Prefecture Jul 2006 Instructor, Tohoku Postal Training Institute Oct 2007 General Manager, Business Department, Sendai Branch, Kampo Life Insurance Co., Ltd. Apr 2010 General Manager, Business Department, Yamagata Branch, Kampo Life Insurance Apr 2012 Branch Manager, Morioka Branch, Kampo Life Insurance Oct 2014 Branch Manager, Sendai Branch, Kampo Life Insurance Apr 2015 Director, Sendai Service Center, Kampo Life Insurance Sep 2015 Executive Officer, Director of Sendai Administrative Service Center, Kampo Life Insurance Apr 2019 Managing Executive Officer, Kampo Life Insurance Sep 2019 Managing Executive Officer, Director of Tokyo Administrative Service Center, Kampo Life Insurance Apr 2020 Managing Executive Officer, General Manager, Tohoku Branch, Japan Post Co., Ltd. Jun 2023 Director of the Company (current) Jun 2025 Advisor, Tohoku Economic Federation (current) Significant Concurrent Positions: Advisor, Tohoku Economic Federation
1959-04-05
Jun KATSURA
Director
Apr 1983 Joined ICI Pharma (now AstraZeneca K.K.) Jan 2000 General Manager, Oncology Business Division, AstraZeneca K.K. Jan 2005 Director, General Manager, Oncology Business Division, AstraZeneca K.K. Aug 2012 Head of Global Portfolio and Product Strategy (Senior Global Marketing Director) for IRESSA, AstraZeneca; Director, AstraZeneca K.K. Aug 2015 Director, General Manager, Oncology Business Division, Merck Serono Co., Ltd. (now Merck Biopharma Co., Ltd.) Jan 2018 Representative, Oncology Business Consulting (current) May 2018 Representative Director, President and CEO, Medical Incubator Japan Co., Ltd. Mar 2021 Outside Director, CareNet, Inc. Mar 2023 Representative Director, President, LinDo Co., Ltd. (current) Jun 2023 Director of the Company (current) Mar 2024 Director, President and CEO, Medical Incubator Japan Co., Ltd. (current) Significant Concurrent Positions: Representative, Oncology Business Consulting; Director, President and CEO, Medical Incubator Japan Co., Ltd.; Representative Director, President, LinDo Co., Ltd.
1961-01-04
Masami TSUGUTA
Director
May 1985 Acquired license as Clinical Laboratory Technician Jun 1985 Acquired license as Pharmacist Apr 1987 Pharmacy Department, Niigata City General Hospital Apr 2006 Infection Control Pharmacist certified by the Japanese Society of Hospital Pharmacists Jul 2007 Head, Pharmacy Department, Niitsu Medical Center Hospital Mar 2010 Antimicrobial Chemotherapy Pharmacist certified by the Japanese Society of Chemotherapy Mar 2014 Doctor of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences Apr 2016 Professor, Faculty of Pharmaceutical Sciences, Center for Clinical Pharmacy Education and Research, Niigata University of Pharmacy and Applied Life Sciences Jan 2020 Infection Control Doctor certified by the ICD Certification Council Apr 2023 Professor, Laboratory of Clinical Infectious Diseases, Department of Clinical Laboratory Science, Faculty of Medical Technology, Niigata University of Pharmacy and Applied Life Sciences (current) Jun 2023 Director of the Company (current) Significant Concurrent Positions: Professor, Laboratory of Clinical Infectious Diseases, Department of Clinical Laboratory Science, Faculty of Medical Technology, Niigata University of Pharmacy and Applied Life Sciences
1962-12-12
Yoshiharu TAKAHASHI
Director, Audit and Supervisory Committee Member
Apr 1986 Joined Sanes Co., Ltd. (now Vital-Net Co., Ltd.) Nov 2004 General Manager, Finance Department, Vital-Net Jul 2008 Executive Officer, General Manager, Finance Department, Vital-Net Apr 2009 General Manager, Corporate Planning Department and General Manager, Accounting and Finance Department, the Company Jul 2020 Executive Officer, General Manager, Accounting and Finance Department, the Company Jul 2022 Executive Officer, General Manager, Corporate Planning Department, the Company Jul 2024 Statutory Auditor, Vital-Net (current) Jun 2025 Director and Audit and Supervisory Committee Member of the Company (current) Significant Concurrent Positions: Statutory Auditor, Vital-Net
1962-04-04
Takeshi NISHITANI
Director, Audit and Supervisory Committee Member
Oct 1999 Joined Asahi Audit Corporation (now Ernst & Young ShinNihon LLC) Apr 2003 Registered as Certified Public Accountant Apr 2008 Joined Keiei Sokyo Kiban Co., Ltd. Feb 2011 Representative Director, Prime Mover Co., Ltd. Jun 2020 Statutory Auditor of the Company Jan 2021 Representative Director, Nihon CGA Co., Ltd. (current) Jun 2023 Director and Audit and Supervisory Committee Member of the Company (current) Significant Concurrent Positions: Representative Director, Nihon CGA Co., Ltd.
1974-04-29
Mamiko IWATA
Director, Audit and Supervisory Committee Member
Oct 2005 Registered as Attorney-at-Law; joined Frontier Law Office Jul 2010 Opened Kotobuki Sogo Law Office Apr 2016 Family Conciliation Commissioner, Sendai Family Court (current) Apr 2020 Director, Miyagi Prefectural Consumers' Cooperative Union (current) Mar 2022 Member, Miyagi Prefectural Council for Gender Equality (current) Jun 2022 Outside Director, Dencodo Co., Ltd. (current) Jan 2023 Opened Forest Up Law Office (current) Apr 2023 Member, Screening Committee, Japan Sport Council (current) Jun 2025 Director and Audit and Supervisory Committee Member of the Company (current) Significant Concurrent Positions: Outside Director, Dencodo Co., Ltd.
1975-08-04
Large Shareholding Reports
No filings
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-08-06
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-19
Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2026-02-10
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-11-14
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2025-08-06
Q1 Earnings Flash
FY ending Mar 2026
EDINETAmended
2025-07-09
Amended Annual Securities Report
Period: Apr 2024 – Mar 2025
EDINETAmended
2025-07-01
Amended Annual Securities Report
Period: Apr 2024 – Mar 2025
EDINETAmended
2025-06-23
Amended Annual Securities Report
Period: Apr 2024 – Mar 2025
EDINET
2025-06-20
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-12
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-08
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-08-06
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-27
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-02-14
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-13
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-09
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINETAmended
2023-06-30
Amended Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-06-30
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-10
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-14
Quarterly Securities Report
EDINET
2022-08-09
Quarterly Securities Report
EDINET
2022-06-29
Annual Securities Report
EDINET
2022-02-10
Quarterly Securities Report
EDINET
2021-11-12
Quarterly Securities Report
EDINET
2021-08-10
Quarterly Securities Report
EDINET
2021-06-28
Annual Securities Report
EDINET
2021-02-10
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →